1. Home
  2. Stock quotes
  3. Amphastar Pharmaceuticals
  4. Financial Statements
Amphastar Pharmaceuticals logo
Amphastar Pharmaceuticals AMPH
$ 45.51 2.14%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Amphastar Pharmaceuticals Financial Statements 2011-2024 | AMPH

Annual Financial Statements Amphastar Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

 2.25 B 1.76 B 1.32 B 825 M 909 M 1.03 B 872 M 690 M 542 M 509 M - - -

Shares

 48.3 M 48.6 M 47.8 M 47 M 47 M 46.4 M 46.1 M 45.4 M 45 M 42 M - - -

Historical Prices

 46.6 36.2 27.7 17.5 15.4 24.9 18.4 15.5 10.5 14 - - -

Net Income

 138 M 91.4 M 62.1 M 1.4 M 48.9 M -5.74 M 4.51 M 10.5 M -2.79 M -10.7 M 11.9 M 18.1 M 7.75 M

Revenue

 644 M 499 M 438 M 350 M 322 M 295 M 240 M 255 M 252 M 210 M 230 M 204 M 118 M

Cost of Revenue

 293 M 250 M 238 M 207 M 190 M 188 M 150 M 151 M 174 M 159 M 143 M 114 M -

Gross Profit

 351 M 249 M 200 M 143 M 132 M 107 M 90.8 M 104 M 77.3 M 51.3 M 87 M 90.3 M 28.1 M

Operating Income

 197 M 107 M 69.9 M 11 M -39 K -8.62 M -1.27 M 15.4 M -6.9 M -18 M 17.5 M 25.4 M -

Interest Expense

 27.2 M 1.85 M 885 K 374 K 119 K 243 K 826 K 1.02 M 987 K 609 K 958 K 784 K -

EBITDA

 223 M 120 M 80.1 M 20 M 21.1 M 7.89 M 11.9 M 30.3 M 6.56 M -3.1 M 30.7 M 39 M -22.3 M

Operating Expenses

 154 M 141 M 130 M 132 M 132 M 116 M 94.3 M 88.5 M 84 M 68.8 M 69.3 M 62.8 M 61.6 M

General and Administrative Expenses

 51.5 M 45.1 M 51.4 M 50.4 M 50.3 M 49.9 M 44.5 M 41.8 M 41.5 M 34.8 M 31 M 27.2 M 26.4 M

All numbers in USD currency

Quarterly Income Statement Amphastar Pharmaceuticals

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

 48.6 M 48.9 M 48.1 M 48.7 M 48.4 M 48 M 48.1 M 48.9 M 48.9 M 48.1 M 47.7 M 48 M 47.7 M 47.5 M 47.5 M 47.5 M 46.8 M 46.4 M 46.8 M 47.2 M 47.1 M 46.7 M 46.3 M 46.2 M 46.6 M 46.5 M 46.2 M 46.1 M 46 M 46.1 M 46.1 M 45.4 M 45 M 45 M 45.1 M 45.3 M 44.8 M 44.6 M 44.6 K 44.6 K 39.8 K 38.8 K 38.7 M 38.7 M 38.7 M 38.7 M - - - - - - - -

Net Income

 40.4 M 37.9 M - 49.2 M 26.1 M 26 M - 15.9 M 17.3 M 24.3 M - 29.5 M 7.77 M 5.04 M - 3.92 M -192 K 3.95 M -1.03 M 1.31 M 47.8 M 868 K 1.87 M 2.39 M -2.85 M -7.14 M 1.47 M 99 K 1.97 M 893 K -2.74 M 3.89 M 6.9 M 2.49 M 7.53 M -3.01 M -6.65 M -665 K -2.52 M -5.38 M -1.18 M -1.62 M 1.83 M -160 K 7.81 M 2.38 M - - - - - - - -

Revenue

 191 M 182 M - 181 M 146 M 140 M - 120 M 123 M 120 M - 112 M 102 M 103 M - 83.4 M 85.8 M 84.7 M 83.4 M 80.1 M 79 M 79.8 M 89.7 M 75.5 M 71 M 58.4 M 60.4 M 57.9 M 65.2 M 56.7 M 63.5 M 64.2 M 68 M 59.4 M 76.9 M 63.9 M 53.9 M 56.9 M 55.9 M 59.7 M 49 M 45.9 M 54.9 M 59.3 M 62.5 M 53 M - - - - - - - -

Cost of Revenue

 89.3 M 87.2 M - 72.2 M 73 M 66.2 M - 61.6 M 60.1 M 64.5 M - 61 M 54.3 M 58.1 M - 46.9 M 52.6 M 47.9 M - 44.9 M 46.7 M 48.9 M - 46.3 M 45 M 41.4 M - 37.4 M 38.4 M 33.8 M - 36.6 M 36.3 M 34.5 M - 46.3 M 40.5 M 43.6 M - 47.9 M 34 M 33.4 M - 39 M 35 M - - - - - - - - -

Gross Profit

 102 M 95.2 M - 108 M 72.7 M 73.8 M - 58.5 M 63.4 M 55.8 M - 51.2 M 47.4 M 44.9 M - 36.5 M 33.2 M 36.8 M 33.4 M 35.3 M 32.4 M 30.9 M 34.7 M 29.3 M 26.1 M 17 M 20.5 M 20.6 M 26.7 M 22.8 M 20 M 27.6 M 31.7 M 24.9 M 33.2 M 17.6 M 13.3 M 13.3 M 12 M 11.8 M 15 M 12.5 M 19.6 M 20.3 M 27.5 M 19.6 M - - - - - - - -

Operating Income

 57 M 55.2 M - 72.7 M 36.9 M 33.4 M - 23.2 M 24.8 M 21.6 M - 24.8 M 10.6 M 10.3 M - 3.52 M -2.92 M 7.48 M - 2.4 M 973 K -3.17 M - 2.55 M -2.94 M -9.78 M - -2.94 M 2.18 M 1.4 M - 5.8 M 10.3 M 4.08 M - -3.75 M -10.3 M -7.26 M - -7.82 M -1.17 M -1.97 M - 226 K 12 M - - - - - - - - -

Interest Expense

 -5.09 M 298 K - 3.46 M -1.52 M 398 K - 566 K 397 K 355 K - 527 K 86 K 104 K - 175 K 35 K 76 K - 22 K 24 K 30 K - 124 K 100 K 18 K - 264 K 237 K 191 K - 281 K 305 K 384 K - 232 K 210 K 341 K - 504 K 476 K 180 K - 195 K 237 K - - - - - - - - -

EBITDA

 66.8 M 64.9 M - 82.3 M 40 M 36.8 M - 26.6 M 27.8 M 24.4 M - 27.3 M 13.2 M 12.8 M - 5.97 M -894 K 9.53 M - 4.1 M 2.63 M -1.54 M - 13 M 3.57 M -6.72 M - 6.72 M 8.42 M 4.5 M - 14.8 M 16.3 M 7.02 M - 4.77 M -4.63 M -4.49 M - 1.42 M 4.86 M 971 K - 8.41 M 17.4 M - - - - - - - - -

Operating Expenses

 44.9 M 39.9 M - 35.7 M 35.8 M 40.4 M - 35.3 M 38.5 M 34.2 M - 26.4 M 36.8 M 34.6 M - 33 M 36.1 M 29.3 M - 32.8 M 31.4 M 34.1 M - 26.7 M 29 M 26.7 M - 23.5 M 24.6 M 21.4 M - 21.8 M 21.4 M 20.8 M - 21.3 M 23.6 M 20.5 M - 19.6 M 16.2 M 14.5 M - 20.1 M 15.5 M - - - - - - - - -

General and Administrative Expenses

 14.8 M 13.3 M - 12.7 M 12.3 M 13.5 M - 12 M 9.98 M 12.5 M - 10.9 M 14.6 M 15.3 M - 11.7 M 15.9 M 10.7 M - 11 M 12.4 M 16.3 M - 13.4 M 11.7 M 11 M - 11.7 M 12.2 M 11.3 M - 10.8 M 9.46 M 10.9 M - 9.03 M 11.3 M 12.5 M - 9.56 M 8.64 M 6.84 M - 9.54 M 6.51 M - - - - - - - - -

All numbers in USD currency